Home/Filings/4/0001618835-20-000194
4//SEC Filing

File Justin J. 4

Accession 0001618835-20-000194

CIK 0001618835other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 4:16 PM ET

Size

4.9 KB

Accession

0001618835-20-000194

Insider Transaction Report

Form 4
Period: 2020-06-12
File Justin J.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2020-06-12$3.14/sh+8,500$26,690250,408 total
Footnotes (1)
  • [F1]The total amount of securities beneficially owned includes 4,303 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on June 12,2020, the last trading day of the purchase period.

Issuer

Evofem Biosciences, Inc.

CIK 0001618835

Entity typeother

Related Parties

1
  • filerCIK 0001726277

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:16 PM ET
Size
4.9 KB